(Q46616751)

23 December 2017

title

Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma (English)

1 reference

23 December 2017

positron emission tomography

main subject

1 reference

Marion T Harris

1

1 reference

23 December 2017

Salvatore U Berlangieri

2

1 reference

23 December 2017

Jonathan S Cebon

3

1 reference

23 December 2017

Ian D Davis

4

1 reference

23 December 2017

Andrew M Scott

5

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

Molecular Imaging and Biology

published in

1 reference

23 December 2017

volume

7

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

304-308

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s11307-005-0002-7

exact match

0 references

cites work

Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma

1 reference

12 December 2020

Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.

1 reference

12 December 2020

Surgical therapy for distant metastases of malignant melanoma

1 reference

12 December 2020

Positron emission tomography in the detection and management of metastatic melanoma

1 reference

12 December 2020

The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma

1 reference

12 December 2020

Positron emission tomography scanning in malignant melanoma

1 reference

12 December 2020

Computed tomography in evaluation of patients with stage III melanoma

1 reference

12 December 2020

PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.

1 reference

12 December 2020

The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making

1 reference

12 December 2020

Effectiveness of positron emission tomography for the detection of melanoma metastases

1 reference

12 December 2020

The Impact of 2-Deoxy-2[18F] Fluoro-D-Glucose Whole Body Positron Emission Tomography for Managing Patients with Melanoma The Referring Physician's Perspective

1 reference

12 December 2020

Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

1 reference

12 December 2020

FDG-PET screening for cerebral metastases in patients with suspected malignancy.

1 reference

12 December 2020

A review of the literature for whole-body FDG PET in the management of patients with melanoma.

1 reference

12 December 2020

18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact

1 reference

12 December 2020

Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients

1 reference

12 December 2020

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

1 reference

12 December 2020

Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy

1 reference

12 December 2020

Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients

1 reference

12 December 2020

10.1007/S11307-005-0002-7

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017